Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 108

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients

Eckert, Gunter P., Hooff, Gero P., Strandjord, Dana M., Igbavboa, Urule, Volmer, Dietrich A., Müller, Walter E., Wood, W. Gibson · 2009 · Neurobiology of Disease

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2009.05.005

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. Bruen, 2008, Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease, Brain, 131, 2455, 10.1093/brain/awn151 · DOI · Paper page
  2. Chetelat, 2008, Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease, Brain, 131, 60, 10.1093/brain/awm288 · DOI · Paper page
  3. Cole, 2006, Isoprenoids and Alzheimer's disease: a complex relationship, Neurobiol. Dis., 22, 209, 10.1016/j.nbd.2005.11.007 · DOI
  4. Cole, 2005, Statins cause intracellular accumulation of APP, beta-secretase cleaved fragments, and Abeta via an isoprenoid-dependent mechanism, J. Biol. Chem., 280, 18755, 10.1074/jbc.M413895200 · DOI
  5. Franke, 2007, Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment, Neurobiol. Dis., 25, 438, 10.1016/j.nbd.2006.10.004 · DOI
  6. Hampton, 2002, Proteolysis and sterol regulation, Annu. Rev. Cell Dev. Biol., 18, 345, 10.1146/annurev.cellbio.18.032002.131219 · DOI
  7. Hooff, 2008, Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP), Anal. Bioanal. Chem., 392, 673, 10.1007/s00216-008-2306-3 · DOI
  8. Johnson-Anuna, 2005, Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex, J. Pharmacol. Exp. Ther., 312, 786, 10.1124/jpet.104.075028 · DOI · Paper page
  9. Kukar, 2005, Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production, Nat. Med., 11, 545, 10.1038/nm1235 · DOI · Paper page
  10. Lee, 2002, Implication of the small GTPase Rac1 in the generation of reactive oxygen species in response to beta-amyloid in C6 astroglioma cells, Biochem. J., 366, 937, 10.1042/bj20020453 · DOI
  11. Li, 2007, Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease, Neurology, 69, 878, 10.1212/01.wnl.0000277657.95487.1c · DOI · Paper page
  12. Lutz, 1992, Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation, J. Biol. Chem., 267, 7983, 10.1016/S0021-9258(18)42396-4 · doi:10.1016/s0021-9258(18)42396-4
  13. McTaggart, 2006, Isoprenylated proteins, Cell Mol. Life Sci., 63, 255, 10.1007/s00018-005-5298-6 · DOI · Paper page
  14. Murthy, 2005, Regulation of fatty acid synthesis by farnesyl pyrophosphate, J. Biol. Chem., 280, 41793, 10.1074/jbc.M504101200 · DOI
  15. Ridley, 2001, Rho proteins: linking signaling with membrane trafficking, Traffic, 2, 303, 10.1034/j.1600-0854.2001.002005303.x · DOI · Paper page
  16. Roskoski, 2003, Protein prenylation: a pivotal posttranslational process, Biochem. Biophys. Res. Commun., 303, 1, 10.1016/S0006-291X(03)00323-1 · DOI
  17. Scheper, 2004, Rab6 membrane association is dependent of Presenilin 1 and cellular phosphorylation events, Brain Res. Mol. Brain Res., 122, 17, 10.1016/j.molbrainres.2003.11.013 · DOI
  18. Scheper, 2007, Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress, Neuropathol. Appl. Neurobiol., 33, 523, 10.1111/j.1365-2990.2007.00846.x · DOI
  19. Sparks, 2008, Reduced risk of incident AD with elective statin use in a clinical trial cohort, Curr. Alzheimer Res., 5, 416, 10.2174/156720508785132316 · DOI · Paper page
  20. Takai, 2001, Small GTP-binding proteins, Physiol. Rev., 81, 153, 10.1152/physrev.2001.81.1.153 · DOI · Paper page
  21. Tong, 2008, Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue, Anal. Biochem., 378, 138, 10.1016/j.ab.2008.04.021 · DOI
  22. Tong, 2005, Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells, Anal. Biochem., 336, 51, 10.1016/j.ab.2004.09.024 · doi:10.1016/j.ab.2004.09.024
  23. Urano, 2005, Association of active gamma-secretase complex with lipid rafts, J. Lipid. Res., 46, 904, 10.1194/jlr.M400333-JLR200 · DOI
  24. Zhou, 2007, Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis, Dement. Geriatr. Cogn. Disord., 23, 194, 10.1159/000099037 · DOI

Cited by

See all 108

Metadata

Authors
Eckert, G. P., Hooff, G. P., Strandjord, D. M., Igbavboa, U., Volmer, D. A., Müller, W. E., & Wood, W. G.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2009-08
Volume
35
Issue
2
Pages
251-257
ISSN
0969-9961
Cited by
108
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.